Recombinant PDGFRA (Tovetumab Biosimilar) anticorps
Aperçu rapide pour Recombinant PDGFRA (Tovetumab Biosimilar) anticorps (ABIN7598059)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Expression System
- Mammalian cells
-
Fonction
- Research Grade Tovetumab Biosimilar Antibody
-
Specificité
- PDGFR2, Platelet-derived growth factor receptor alpha, RHEPDGFRA, Alpha platelet-derived growth factor receptor, PDGFR-2, Platelet-derived growth factor alpha receptor, Platelet-derived growth factor receptor 2, PDGF-R-alpha, Alpha-type platelet-derived growth factor receptor, CD140a antigen, CD140 antigen-like family member A, PDGFRA, PDGFR-alpha, CD140a
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Pureté
- >95 % by SDS-PAGE.
-
Isotype
- IgG2 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Date de péremption
- 12 months
-
-
- PDGFRA (Tovetumab Biosimilar)
-
Autre désignation
- Tovetumab Biosimilar
-
Classe de substances
- Biosimilar
-
Sujet
- PDGFR2, Platelet-derived growth factor receptor alpha, RHEPDGFRA, Alpha platelet-derived growth factor receptor, PDGFR-2, Platelet-derived growth factor alpha receptor, Platelet-derived growth factor receptor 2, PDGF-R-alpha, Alpha-type platelet-derived growth factor receptor, CD140a antigen, CD140 antigen-like family member A, PDGFRA, PDGFR-alpha, CD140a
-
UniProt
- P16234
-
Numéro CAS
- 1243266-04-7
Antigène
-